A Trial of Treatment With Lenalidomide-Melphalan-Dexamethasone in Patients With Primary (AL) Amyloidosis (LEOMEX)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00883623
Recruitment Status : Completed
First Posted : April 17, 2009
Last Update Posted : November 25, 2013
Gesellschaft für Medizinische Innovation - Hämatologie und Onkologie mbH
Information provided by (Responsible Party):
Dr. Stefan Schönland, Heidelberg University